T
ABBV icon

TNF’s AbbVie ABBV Stock Holding History

TNF’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$286K Sell
1,510
-172
-10% -$32.1K 0.1% 92
2024
Q2 		$296K Hold
1,682
– – 0.11% 91
2024
Q1 		$282K Sell
1,682
-22
-1% -$3.79K 0.11% 88
2023
Q4 		$279K Sell
1,704
-473
-22% -$69K 0.11% 84
2023
Q3 		$317K Buy
2,177
+14
+0.6% +$2.06K 0.15% 70
2023
Q2 		$291K Hold
2,163
– – 0.13% 73
2023
Q1 		$327K Hold
2,163
– – 0.15% 67
2022
Q4 		$314K Hold
2,163
– – 0.14% 78
2022
Q3 		$299K Hold
2,163
– – 0.15% 75
2022
Q2 		$321K Sell
2,163
-1,070
-33% -$164K 0.15% 78
2022
Q1 		$501K Buy
3,233
+10
+0.3% +$1.45K 0.23% 58
2021
Q4 		$438K Sell
3,223
-122
-4% -$14.4K 0.18% 73
2021
Q3 		$406K Buy
+3,345
New +$382K 0.17% 76

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

TNF's ABBV Position: Q3 2024 in Review

TNF reduced its AbbVie (ABBV) stake by 10% in Q3 2024, selling an estimated $32.1K and leaving 1,510 shares worth $286K. The position accounts for 0.1% of the portfolio, ranked #92.

TNF first reported a position in ABBV in Q3 2021 and has held it in 13 quarters since. The position peaked at $501K in Q1 2022. 3,498 funds tracked by Wall St. Rank hold ABBV as of Q3 2024.

  • TNF held 1,510 shares of AbbVie worth $286K as of Q3 2024.
  • TNF sold 172 AbbVie shares in Q3 2024, an estimated $32.1K.
  • AbbVie made up 0.1% of TNF's portfolio in Q3 2024, its #92 holding.
  • TNF first reported a position in AbbVie in Q3 2021 and has held it in 13 quarters since.
  • TNF's AbbVie position peaked at $501K in Q1 2022.
  • 3,498 funds tracked by Wall St. Rank held AbbVie as of Q3 2024.

Based on TNF's 13F filing for Q3 2024, filed 25 Oct 2024.